What's new

Human medicines European public assessment report (EPAR): Paxneury, guanfacine, Date of authorisation: 26/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR): Paxneury, guanfacine, Date of authorisation: 26/02/2025, Status: Authorised

Mar 11, 2025 - 16:39
 0
Human medicines European public assessment report (EPAR): Paxneury, guanfacine, Date of authorisation: 26/02/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Paxneury, guanfacine, Date of authorisation: 26/02/2025, Status: Authorised
Read More

Tags:

Previous Article

Knight Therapeutics stacks its Canadian armor with $99M Paladin buy

Next Article

How The US Lost The Floating Wind Turbine Race

Related Posts

Human medicines European public assessment report (EPAR): Omvoh, mirikizumab, Date of authorisation: 26/05/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Copalia HCT, amlodipine,valsartan,hydrochlorothiazide, Date of authorisation: 03/11/2009, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 12, 2025  0

Medicinal products for human use: monthly figures - Jan...

Feb 25, 2025  0